Loading...
Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining T(reg) and antitumor CTL function
Graft-versus-host disease (GVHD) is a leading cause of nonrelapse mortality after allogeneic hematopoietic cell transplantation. T cell costimulation by CD28 contributes to GVHD, but prevention is incomplete when targeting CD28, downstream mammalian target of rapamycin (mTOR), or Aurora A. Likewise,...
Saved in:
Published in: | Sci Transl Med |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
2017
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6368389/ https://ncbi.nlm.nih.gov/pubmed/28077684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aai8269 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|